SCHEMBL477493

SCHEMBL477493

CCCCN(C(=O)O)c1ccc([N+](=O)[O-])cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.50
POLB P06746 1/20 0.48
MAPT P10636 3/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP1A2 P05177 1/20 0.42
GAA P10253 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
CYP2C19 P33261 1/20 0.40
ADRA2A P08913 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
HCAR3 P49019 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477491 1.00 PKM (0.50) PKMPOLBMAPTMEN1KMT2A
SCHEMBL14228975 0.82 PKM (0.52) PKMPOLBMAPTMEN1KMT2A
SCHEMBL14228971 0.80 PKM (0.50) PKMPOLBMAPTMEN1KMT2A
SCHEMBL4065147 0.79 ALDH1A1 (0.45) MAPTMEN1KMT2AGAANPC1
SCHEMBL10428506 0.77 PKM (0.50) PKMPOLBMAPTMEN1KMT2A
SCHEMBL3891691 0.76 PKM (0.55) PKMPOLBMAPTMEN1KMT2A
SCHEMBL14229723 0.75 PKM (0.46) PKMPOLBMAPTMEN1KMT2A
SCHEMBL16706322 0.75 PKM (0.68) PKMPOLBMAPTMEN1KMT2A
SCHEMBL14230034 0.74 MAPT (0.47) PKMPOLBMAPTMEN1KMT2A
SCHEMBL14200794 0.74 PKM (0.45) PKMPOLBMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411387-A2 PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLE SULFONAMIDES AND THEIR USE IN CANCER THERAPY Pathway Therapeutics, Inc. (US) 2012-02-01 EP disclosed
WO-2010110685-A2 PYRIMDDINYL AND 1,3,5-TRIAZINYL BENZIMTOAZOLE SULFONAMIDES AND THEIR USE IN CANCER THERAPY PATHWAY THERAPEUTICS LIMITED (NZ) 2010-09-30 WO disclosed